Cytori Therapeutics (NSDQ:CYTX) said today that it priced an underwritten public offering of 8.6 million shares of common stock at $1.10 apiece. The company plans to bring in $9.5 million.
Cytori granted a 45-day underwriter’s option to purchase up to 15% of additional shares of common stock. The offering is expected to close on April 17 this year.
Cytori said it plans to use the net proceeds of its offering for working capital and general corporate purposes.
Get the full story at our sister site, Drug Delivery Business News.